Drug Profile
Epi-cochlioquinone A
Alternative Names: Epicochlioquinone ALatest Information Update: 20 May 1999
Price :
$50
*
At a glance
- Originator Sankyo
- Class Antihyperlipidaemics
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypercholesterolaemia
Most Recent Events
- 20 May 1999 No-Development-Reported for Hypercholesterolaemia in Japan (Unknown route)
- 07 Oct 1996 New profile
- 07 Oct 1996 Preclinical development for Hypercholesterolaemia in Japan (Unknown route)